I highly doubt it will. They achieved the goals of the capital raise which was to reduce gearing, weather the storm and be in a healthy capital position to scoop up cheap debt which was inevitably going to happen. Any competition without a healthy balance sheet is going to be feeling the pain right now.
CCP is very much positioned for some serious growth in the mid-term horizon - they have outperformed the ASX200 consistently in any time horizon even through the GFC
- Forums
- ASX - By Stock
- CCP
- Ann: FY2020 Unaudited results update
Ann: FY2020 Unaudited results update, page-10
-
-
- There are more pages in this discussion • 55 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CCP (ASX) to my watchlist
(20min delay)
|
|||||
Last
$14.30 |
Change
-0.080(0.56%) |
Mkt cap ! $975.3M |
Open | High | Low | Value | Volume |
$14.60 | $14.60 | $14.30 | $734.2K | 50.95K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
18 | 1102 | $14.30 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$14.31 | 681 | 23 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
15 | 1182 | 14.300 |
4 | 362 | 14.290 |
4 | 361 | 14.280 |
3 | 327 | 14.270 |
6 | 1120 | 14.260 |
Price($) | Vol. | No. |
---|---|---|
14.320 | 774 | 22 |
14.330 | 398 | 4 |
14.340 | 554 | 7 |
14.350 | 2108 | 8 |
14.360 | 749 | 5 |
Last trade - 14.11pm 15/07/2024 (20 minute delay) ? |
Featured News
CCP (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online